Exploring the Novelty in Lipid Profiling of Patients: A Non-fasting Approach from Eastern India

Objective To date, no reference interval is available for lipid profile, including total cholesterol (TC), triglycerides (TGs), high-density lipoprotein (HDL), or low-density lipoprotein (LDL)-cholesterol, etc., in a non-fasting state. Hence, the study was taken up with the objective of exploring the possibility of establishing a reference interval for non-fasting lipid profile consisting of serum TC, TG, LDL, HDL, and very low-density lipoprotein (VLDL) cholesterol. Materials and Methods A total of 1,350 apparently healthy subjects, including 636 healthy men and 714 healthy women of 18 years and beyond of age, were enrolled in the study. Reference individuals were recruited using cluster sampling method from various villages and semi-urban regions irrespective of their sex, religion, socioeconomic status, or any other demographic profile, and samples were analyzed in Beckman Coulter AU480 analyzer. Results The mean age of 1,350 participants was 38.23 ± 15.94 years. We found that all the test parameters require a different reference interval than the established fasting reference range, except for HDL cholesterol in females. The data were subdivided into subjects below 40 years, between 40 and 60 years, and older than 60 years of age. All five parameters in the lipid profile were individually analyzed and were compared age group-wise and gender-wise with the total study population. Significant differences in the various dataset were found. Conclusion A shift toward non-fasting lipid interval measurement is, thus, a piece of evidence-driven mechanism. Even from a patient's perspective, it sets in ease and convenience in lipid-profile testing, subsequently leading to a more compliant cardiovascular management and monitoring

Association of immune status with haematology and inflammatory markers in treatment naïve HIV positive patients from a tertiary health care institute

505-510High and low serum ferritin level in HIV patients is associated with the progression of disease with lowering of CD4 cell count in both adults and children. Elevated C-Reactive protein (CRP) has been a better predictor of child mortality and maternal disease progression to Acquired immuno deficiency syndrome (AIDS). Data related to ferritin, CRP together with anaemia and immune status in early stage of ART naïve HIV infection is scarce. Here, we evaluated haematological parameters, inflammatory markers like serum ferritin, CRP level and their association with immune status in Antiretroviral therapy (ART) naïve HIV positive cases. After obtaining written consent, 55 screening test (Meriscreen) positive & HIV-TRIDOT confirmed, antiretroviral treatment naïve patients above 18 years from both gender were included in the study. Serum ferritin, CRP and other haematological parameters were analysed along with CD4 and CD8 count. Anaemia found prominent in group having CD4 count less than 200 cells/μL with a significant fall in Hb%. Inflammatory parameters ferritin and CRP analyzed with respect to CD4 cells documented reverse phenomena in these cases. Significant inverse relation of ferritin with Hb%, total WBC and absolute lymphocyte count points towards concurrent presence of anaemia and leukopenia with inflammation in HIV cases. The results suggest that inflammatory markers like ferritin induced by cytokines may be considered as an auxiliary parameter for assessing disease severity in HIV positive cases at time of diagnosis for early therapeutic intervention

Effect of Metformin on Hormonal and Biochemical Profile in PCOS Before and After Therapy

Insulin resistance and the resultant hyperinsulinemia exacerbate the reproductive abnormalities of Polycystic Ovarian Syndrome by increasing ovarian androgen productions and decreasing serum sex hormone binding globulin. The present study was conducted to estimate serum insulin and testosterone level in 44 PCOS cases and 32 control patients. Simultaneously the role of metformin (an insulin sensitizing agent) in modulating insulin resistance and serum androgen level was also analyzed. A significant rise in serum insulin and testosterone (P < 0.001) was observed in cases in comparison to control. Fasting Plasma Glucose to insulin ratio, a marker of insulin resistance revealed a significant fall in PCOS group. Follow up of cases with metformin for 3 months revealed a significant fall in serum insulin (P < 0.05) with improvement in insulin resistance along with a nonsignificant fall in testosterone level. Serum insulin registered a significant positive correlation (P < 0.05) with serum testosterone revealing its etiological association. Thus administration of drugs ameliorating insulin levels is expected to provide new therapeutic modality for PCOS

Serum total PSA and free PSA in breast tumors

Now a days measurement of molecular forms of PSA has gained importance in clinical practice. Several studies have demonstrated the production of PSA in female tissues, such as breast. The present piece of work has been undertaken with an objective to estimate the relative proportion of the molecular forms of PSA in serum along with serum testosterone in benign and malignant breast tumor cases and to analyze their association with the severity of the disease process 34 malignant and 26 benign breast disease cases along with 33 healthy controls of same age group were enrolled in this study for evaluation. Serum testosterone was measured by ELISA, whereas serum total PSA (TPSA) and free PSA (FPSA) were estimated by electrochemiluminescence immunoassay. A significant rise of fasting plasma glucose along with prominent dyslipidemia was observed in breast tumor cases. Marked rise in serum testosterone as well as TPSA and FPSA was documented in both benign and malignant breast tumor cases. Serum testosterone revealed a significant positive association with both TPSA and FPSA pointing towards an etiological association between them. However, surgical removal of tumor mass resulted in a marked decline of presurgical value of both TPSA and FPSA with a non-significant fall in serum testosterone revealing tumor tissue as the source of FPSA and TPSA. Thus, estimation of PSA provides prognostic information that may assist in future treatment